Desloratadine Glenmark


Tablet 10 30
scheduling status
S2
registration number
48/5.7.1/1257
What Desloratadine Glenmark is and what it is used for
DESLORATADINE GLENMARK is indicated for the relief of symptoms associated with allergic rhinitis. DESLORATADINE GLENMARK is also indicated for the short-term relief of symptoms associated with chronic idiopathic urticaria.
dosage
Adults and adolescents (≥ 12 years of age): One DESLORATADINE GLENMARK tablet once a day regardless of mealtime.
how to take
For oral use with or without food. Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week of for less than 4 weeks) should be managed in accordance with the evaluation of the patient’s disease history. Treatment can be discontinued after symptoms are resolved and re-initiated upon their reappearance. In persistent allergic rhinitis (presence of symptoms for more than 4 days or more per week or for more than 4 weeks), continued treatment may be proposed to patients during allergen exposure periods. Improvement of symptoms associated with seasonal allergic rhinitis, usually becomes noticeable within 1 to 2 hours after administration of DESLORATADINE GLENMARK.
What Desloratadine Glenmark contains
Each tablet contains 5 mg desloratadine.
other ingredients
Lactose monohydrate, magnesium stearate, maize starch, microcrystalline cellulose, silica colloidal anhydrous.
Therapeutic classification
R06AX27.
© 2026 SAHPRA. ALL RIGHTS RESERVED